Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Current Deferred Revenue (2023 - 2025)

Historic Current Deferred Revenue for NeuroPace (NPCE) over the last 3 years, with Q3 2025 value amounting to $649000.0.

  • NeuroPace's Current Deferred Revenue fell 1335.11% to $649000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $649000.0, marking a year-over-year decrease of 1335.11%. This contributed to the annual value of $600000.0 for FY2024, which is 4545.45% down from last year.
  • As of Q3 2025, NeuroPace's Current Deferred Revenue stood at $649000.0, which was down 1335.11% from $700000.0 recorded in Q2 2025.
  • NeuroPace's Current Deferred Revenue's 5-year high stood at $1.1 million during Q4 2023, with a 5-year trough of $600000.0 in Q4 2024.
  • Over the past 3 years, NeuroPace's median Current Deferred Revenue value was $724500.0 (recorded in 2024), while the average stood at $775875.0.
  • In the last 5 years, NeuroPace's Current Deferred Revenue tumbled by 4545.45% in 2024 and then tumbled by 1335.11% in 2025.
  • Over the past 3 years, NeuroPace's Current Deferred Revenue (Quarter) stood at $1.1 million in 2023, then crashed by 45.45% to $600000.0 in 2024, then increased by 8.17% to $649000.0 in 2025.
  • Its last three reported values are $649000.0 in Q3 2025, $700000.0 for Q2 2025, and $700000.0 during Q1 2025.